Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087553 · ClinicalTrials.gov registry record
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 120
- Enrollment target
NCT02087553 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 120 participants.
The verdict
NCT02087553 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The investigators hypothesize that the storage-damaged red cells are responsible for some of the adverse effects of transfusion. In this observational study, the investigators will measure various laboratory parameters both before and after transfusion in a pediatric intensive care unit to determine at what duration of storage is there laboratory evidence of refrigerator storage damage. The investigators hypothesize that increasing storage time of packed red blood cells (PRBCs) transfused will be associated with increasing non-transferrin-bound iron (NTBI), pro-inflammatory cytokine concentrations, and enhanced microbial growth in vitro in pediatric patients.
Interventions
- BIOLOGICAL Transfusion of red blood cells
- BIOLOGICAL Infusion of albumin/saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-12 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02087553
The ClinicalTrials.gov registry entry for NCT02087553 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transfusion of red blood cells is the first listed.
NCT02087553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02087553 about?
NCT02087553 is a clinical study titled "PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions". The investigators hypothesize that the storage-damaged red cells are responsible for some of the adverse effects of transfusion. In this observational study, the investigators will measure various laboratory parameters both before and after transfusion in a pediatric intensive care unit to determine...
What is the current status of trial NCT02087553?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-12. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02087553?
The interventions under investigation include: Transfusion of red blood cells (BIOLOGICAL), Infusion of albumin/saline (BIOLOGICAL).
Who is sponsoring clinical trial NCT02087553?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.